MindMed is a clinical-stage biopharmaceutical company focused on developing innovative drug candidates to treat brain health disorders, including psychiatry, addiction, pain, and neurology. The company aims to be a global leader in treating these conditions by targeting serotonin, dopamine, and acetylcholine systems. MindMed trades on the NASDAQ (MNMD) and NEO Exchange (MMED).
MindMed is seeking a Vice President of Market Access to lead the strategic development and execution of market access initiatives for their innovative pipeline products, targeting neurotransmitter pathways in the mental health space. This role focuses on securing formulary placement, reimbursement, pricing, and distribution, ensuring patient access to MM120. The ideal candidate is collaborative, creative, and a leader in a fast-paced startup environment.
MindMed is a clinical-stage biopharmaceutical company focused on developing innovative drug candidates to treat brain health disorders, including psychiatry, addiction, pain, and neurology. The company aims to be a global leader in treating these conditions by targeting serotonin, dopamine, and acetylcholine systems. MindMed trades on the NASDAQ (MNMD) and NEO Exchange (MMED).